Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
ProMetic Life Sciences Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'ProMetic Life Sciences Inc. - Product Pipeline Review - 2014', provides an overview of the ProMetic Life Sciences Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ProMetic Life Sciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of ProMetic Life Sciences Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of ProMetic Life Sciences Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the ProMetic Life Sciences Inc.'s pipeline products Reasons to buy - Evaluate ProMetic Life Sciences Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of ProMetic Life Sciences Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the ProMetic Life Sciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of ProMetic Life Sciences Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of ProMetic Life Sciences Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of ProMetic Life Sciences Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 ProMetic Life Sciences Inc. Snapshot 5 ProMetic Life Sciences Inc. Overview 5 Key Information 5 Key Facts 5 ProMetic Life Sciences Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 ProMetic Life Sciences Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 ProMetic Life Sciences Inc. - Pipeline Products Glance 13 ProMetic Life Sciences Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 ProMetic Life Sciences Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 ProMetic Life Sciences Inc. - Drug Profiles 15 PBI-1402 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 PBI-1522 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 PBI-1607 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 PBI-1668 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 PBI-1737 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 PBI-4050 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 PBI-4419 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 PBI-4494 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 ProMetic Life Sciences Inc. - Pipeline Analysis 24 ProMetic Life Sciences Inc. - Pipeline Products by Route of Administration 24 ProMetic Life Sciences Inc. - Pipeline Products by Molecule Type 25 ProMetic Life Sciences Inc. - Recent Pipeline Updates 26 ProMetic Life Sciences Inc. - Dormant Projects 29 ProMetic Life Sciences Inc. - Locations And Subsidiaries 30 Head Office 30 Other Locations & Subsidiaries 30 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 33 Disclaimer 33
List of Tables ProMetic Life Sciences Inc., Key Information 5 ProMetic Life Sciences Inc., Key Facts 5 ProMetic Life Sciences Inc. - Pipeline by Indication, 2014 8 ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2014 9 ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2014 10 ProMetic Life Sciences Inc. - Partnered Products in Pipeline, 2014 11 ProMetic Life Sciences Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 ProMetic Life Sciences Inc. - Phase II, 2014 13 ProMetic Life Sciences Inc. - Preclinical, 2014 14 ProMetic Life Sciences Inc. - Pipeline by Route of Administration, 2014 24 ProMetic Life Sciences Inc. - Pipeline by Molecule Type, 2014 25 ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2014 26 ProMetic Life Sciences Inc. - Dormant Developmental Projects,2014 29 ProMetic Life Sciences Inc., Other Locations 30 ProMetic Life Sciences Inc., Subsidiaries 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.